Nautilus Biotechnology (NAUT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
17 Jun, 2026Opening remarks and agenda
The meeting was called to order by the CEO, who introduced the board members, corporate officers, auditors, legal counsel, and inspector of election present virtually.
The agenda included formal business, voting on proposals, and a Q&A session with stockholders.
Corporate governance
Notice of the meeting and proxy materials were mailed to all stockholders of record, and proof of mailing was filed with the meeting minutes.
A quorum was confirmed, allowing the meeting to proceed with voting on all matters.
Voting was conducted virtually and by proxy, with each share entitled to one vote.
Board and executive committee updates
Two Class II directors were up for election, with nominations closed as no additional candidates were proposed by stockholders.
The board consists of seven directors divided into three classes with staggered terms.
Latest events from Nautilus Biotechnology
- Launch delayed to late 2026; net loss rose 11% to $70.8M; cash runway through 2027.NAUT
Q4 20249 Jul 2026 - Comprehensive proteomics platform targets full proteome analysis with launch planned for late next year.NAUT
Morgan Stanley 23rd Annual Global Healthcare Conference9 Jul 2026 - Operating expenses fell 14% and net loss narrowed as platform commercialization advanced.NAUT
Q1 20268 Jul 2026 - Next-gen proteomics platform set for 2025 launch, targeting deep, accessible protein analysis.NAUT
Goldman Sachs 45th Annual Global Healthcare Conference8 Jul 2026 - Q3 net loss was $16.4M, cash $221.2M, launch targeted for late 2025, milestones delayed.NAUT
Q3 20248 Jul 2026 - A novel proteomics platform promises to revolutionize drug discovery and precision medicine.NAUT
Investor Summit Virtual Conference2 May 2026 - Board recommends all proposals, annual say-on-pay, and highlights strong governance and compliance.NAUT
Proxy filing28 Apr 2026 - Annual meeting to elect directors, ratify auditor, and vote on executive pay and its frequency.NAUT
Proxy filing28 Apr 2026 - New proteomics platform promises comprehensive, reproducible protein analysis with broad applications.NAUT
TD Cowen 46th Annual Health Care Conference2 Mar 2026